A SARC global collaborative phase II trial of R1507, a recombinant human monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R) in patients with recurrent or refractory sarcomas

被引：0
|
作者：
Patel, S.
Pappo, A.
Crowley, J.
Reinke, D.
Eid, J.
Ritland, S.
Chawla, S.
Staddon, A.
Maki, R.
Vassal, G.
Helman, L.
机构：
[1] Sarcoma Alliance Res & Collaborat, Ann Arbor, MI USA
[2] Hoffman La Roche, Nutley, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10503
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Activity of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R), in patients (pts) with recurrent or refractory Ewing's sarcoma family of tumors (ESFT): Results of a phase II SARC study
    Pappo, A. S.
    Patel, S.
    Crowley, J.
    Reinke, D. K.
    Staddon, A. P.
    Kuenkele, R.
    Chawla, S. P.
    Benjamin, R. S.
    Helman, I. J.
    Baker, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] A phase I study of R1507, a human monoclonal antibody IGF-1R (insulin-like growth factor receptor) antagonist in patients with advanced solid tumors
    Gore, Lia
    Aisner, Joseph
    Kurzrock, Razelle
    McCarthy, Cinara D.
    Winter, Erica
    Grippe, Joseph
    Frankel, Stanley
    Mita, Alain
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [3] A Phase 2 Trial of R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients With Recurrent or Refractory Rhabdomyosarcoma, Osteosarcoma, Synovial Sarcoma, and Other Soft Tissue Sarcomas Results of a Sarcoma Alliance for Research Through Collaboration Study
    Pappo, Alberto S.
    Vassal, Gilles
    Crowley, John J.
    Bolejack, Vanessa
    Hogendoorn, Pancras C. W.
    Chugh, Rashmi
    Ladanyi, Marc
    Grippo, Joseph F.
    Dall, Georgina
    Staddon, Arthur P.
    Chawla, Sant P.
    Maki, Robert G.
    Araujo, Dejka M.
    Geoerger, Birgit
    Ganjoo, Kristen
    Marina, Neyssa
    Blay, Jean-Yves
    Schuetze, Scott M.
    Chow, Warren A.
    Helman, Lee J.
    CANCER, 2014, 120 (16) : 2448 - 2456
  • [4] R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study
    Pappo, Alberto S.
    Patel, Shreyaskumar R.
    Crowley, John
    Reinke, Denise K.
    Kuenkele, Klaus-Peter
    Chawla, Sant P.
    Toner, Guy C.
    Maki, Robert G.
    Meyers, Paul A.
    Chugh, Rashmi
    Ganjoo, Kristen N.
    Schuetze, Scott M.
    Juergens, Heribert
    Leahy, Michael G.
    Geoerger, Birgit
    Benjamin, Robert S.
    Helman, Lee J.
    Baker, Laurence H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (34) : 4541 - 4547
  • [5] A phase I study of R1507, a human monoclonal antibody lGF1R (insulin-like growth factor receptor) antagonist given weekly in patients with advanced solid tumors
    Leong, Stephen
    Gore, Lia
    Benjamin, Robert
    Warren, Terri L.
    Eckhardt, S. Gail
    Camidge, D. Ross
    Dias, Cinara
    Greig, Gerald
    Frankel, Stanley R.
    Kurzrock, Razelle
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3360S - 3360S
  • [6] Targeting insulin-like growth factor-1 receptor (IGF1R) for brain delivery of biologics
    Alata, Wael
    Yogi, Alvaro
    Brunette, Eric
    Delaney, Christie E.
    van Faassen, Henk
    Hussack, Greg
    Iqbal, Umar
    Kemmerich, Kristin
    Haqqani, Arsalan S.
    Moreno, Maria J.
    Stanimirovic, Danica B.
    FASEB JOURNAL, 2022, 36 (03):
  • [7] A common polymorphism in exon 16 of the human insulin-like growth factor-1 receptor gene (IGF1R)
    AbuAmero, S
    Preece, M
    Wakeling, E
    Moore, G
    Stanier, P
    MOLECULAR AND CELLULAR PROBES, 1997, 11 (05) : 381 - 383
  • [8] Insulin-like growth factor-1 receptor (IGF1R) as a novel target in chronic lymphocytic leukemia
    Yaktapour, Niuscha
    Uebelhart, Rudolf
    Schueler, Julia
    Aumann, Konrad
    Dierks, Christine
    Burger, Meike
    Pfeifer, Dietmar
    Jumaa, Hassan
    Veelken, Hendrik
    Brummer, Tilman
    Zirlik, Katja
    BLOOD, 2013, 122 (09) : 1621 - 1633
  • [9] A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid Tumors
    Kurzrock, Razelle
    Patnaik, Amita
    Aisner, Joseph
    Warren, Terri
    Leong, Stephen
    Benjamin, Robert
    Eckhardt, S. Gail
    Eid, Joseph E.
    Greig, Gerard
    Habben, Kai
    McCarthy, Cinara D.
    Gore, Lia
    CLINICAL CANCER RESEARCH, 2010, 16 (08) : 2458 - 2465
  • [10] Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non-Small-Cell Lung Cancer
    Ramalingam, Suresh S.
    Spigel, David R.
    Chen, David
    Steins, Martin B.
    Engelman, Jeffrey A.
    Schneider, Claus-Peter
    Novello, Silvia
    Eberhardt, Wilfried E. E.
    Crino, Lucio
    Habben, Kai
    Liu, Lian
    Jaenne, Pasi A.
    Brownstein, Carrie M.
    Reck, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (34) : 4574 - 4580
12345